Vimarsana
Biggest News Aggregation in the World

Page 49 - Compass Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compass Pathways Today - Breaking & Trending Today

New Regulations for Psychedelics? Here's What Investors Need to Know - Vimarsana News

New Regulations for Psychedelics? Here's What Investors Need to Know

There are a couple of proposed regulations and policies in the pipeline.

Source: fool.com
Alvotech Expands its Board of Directors as part of Transition from Private to Publicly Traded Company - Vimarsana News

Alvotech Expands its Board of Directors as part of Transition from Private to Publicly Traded Company

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
A new dawn for psychedelics? - Vimarsana News

A new dawn for psychedelics?

MDMA, magic mushrooms, DMT and acid have all had their day as recreational drugs. Now scientists — and companies — are hopeful these could be the game-changing medicines needed for mental health disorders.

Psychedelics: Michael Pollan on Netflix's 'How to Change Your Mind' - Vimarsana News

Psychedelics: Michael Pollan on Netflix's 'How to Change Your Mind'

Interview with journalist Michael Pollan whose book 'How to Change Your Mind' has been adapted into a four-part Netflix series.

Freedom to Operate Issues Statement Regarding U.S. Patent Trial and Appeal Board's Response to Petition for Post Grant Review of Compass Psilocybin Patents - Vimarsana News

Freedom to Operate Issues Statement Regarding U.S. Patent Trial and Appeal Board's Response to Petition for Post Grant Review of Compass Psilocybin Patents

/PRNewswire/ -- The non-profit Freedom to Operate (FTO) today issued the following statement regarding the U.S. Patent Trial and Appeal Board's (PTAB) response...